Assessing Antimicrobial Prescribing Patterns and Antimicrobial Resistance in Dhi Qar Governorate Hospitals; A retrospective study.

Authors

  • Basma Zuheir Al-Metwali Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
  • Hasan A. Shubbar Ministry of Health, Dhi Qar Health Directorate, Dhi-Qar, Iraq.

DOI:

https://doi.org/10.31351/vol34iss2pp215-226

Keywords:

Antibiotic practice, Antibiograms, Antimicrobial resistance, Antimicrobial stewardship programs, AWaRe classification

Abstract

Antimicrobial resistance (AMR) is a global concern, especially in low- and middle-income countries, threatening food production, healthcare, and life expectancy. Antimicrobial stewardship (AMS) programs can optimize antibiotic use, improve patient outcomes, lower AMR, and save healthcare costs. This observational-retrospective study in Dhi Qar Governorate aimed to assess antimicrobial prescribing patterns in Al-Nasiriya public hospitals. Dhi Qar Health Directorate comprises ten hospitals, and only one hospital was excluded from the study. The study used data from antibiotic stewardship committees, including antibiogram, antibiotic, and meropenem surveys, hospital pharmacies’ medical files, and the directorate statistics from 1/1/2023 to 1/10/2023. The number of patients undergoing antibiotic screening was 6090. Most patients (43.34%) were in the 18–49 years age range. Most cases of antibiotics' clinical indication were surgical procedures (41.82%), with cesarean sections being the most common (16.15%), followed by medical treatment (37.25%), with respiratory conditions (21.34%) being the most common. Most patients (99.72%) received empirical rather than targeted treatment, parenteral rather than oral treatment (98.93% were given parenteral antibiotics); more than half of patients (52.84%) were prescribed a combination of two or more antibiotics. Most cases (95.43%) in antibiotic screening were continued on the same dose without reviewing the antibiotic prescription after 48–72 hours. The treatment resulted in 87.75% healing, 53.57% discharge with antibiotic discontinuation, and a 1.21% death rate among patients. Metronidazole, ceftriaxone, meropenem, amoxicillin, and cefotaxime were the most frequently prescribed antibiotics. The data from hospital pharmacies’ medical files showed the consumption of 14 types of antibiotics within the WHO's Watch group and 18 within the Access group. The most antibiogram-isolated bacteria were E. coli (19.06%), Staphylococcus non-aureus spp. (18.74%), Staphylococcus aureus (11.26%), Klebsiella pneumonia (10.15%), and Pseudomonas aeruginosa (7.88%). The antibiogram showed resistance to many antibiotics, and there was a significant difference in resistance distribution among the Access, Watch, and Reserve groups (P value = 0.024). Antibiotic practice showed empirical treatment with broad-spectrum antibiotics (most of which are in the WHO Watch group), limited culture and sensitivity testing, and limited antibiogram use, making monitoring antibiotic resistance hard. 

How to Cite

1.
Basma Zuheir Al-Metwali, Hasan A. Shubbar. Assessing Antimicrobial Prescribing Patterns and Antimicrobial Resistance in Dhi Qar Governorate Hospitals; A retrospective study. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2025 Jun. 25 [cited 2025 Jun. 27];34(2):215-26. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3838

Publication Dates

Received

2024-05-28

Revised

2025-07-24

Accepted

2024-10-22

Published Online First

2025-06-25

References

Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, Mohamed MG. Antimicrobial resistance: impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health. 2024 Apr 1;2:100081.

Sriram A, Kalanxhi E, Kapoor G, Craig J, Balasubramanian R, Brar S, Criscuolo N, Hamilton A, Klein E, Tseng K, Van Boeckel T. State of the world’s antibiotics 2021: A global analysis of antimicrobial resistance and its drivers. Center for Disease Dynamics, Economics & Policy: Washington, DC, USA. 2021 Jun 5:1-15.

Browne AJ, Chipeta MG, Haines-Woodhouse G, Kumaran EP, Hamadani BH, Zaraa S, Henry NJ, Deshpande A, Reiner RC, Day NP, Lopez AD. Global antibiotic consumption and usage in humans, 2000–18: a spatial modelling study. The Lancet Planetary Health. 2021 Dec 1;5(12):e893-904.

Almansour AM, Alhadlaq MA, Alzahrani KO, Mukhtar LE, Alharbi AL, Alajel SM. The silent threat: antimicrobial-resistant pathogens in food-producing animals and their impact on public health. Microorganisms. 2023 Aug 22;11(9):2127.

Alhilfi RA, Abdulmahdi R, Amr N. Antimicrobial Resistance Annual Report Iraq 2022. Antimicrobial Resistance Surveillance System. Ministry of Health. Available from: http://www.phd.iq/catalog/AMR_Iraq_2022. Accessed May 6, 2024.

Akualing JS, Rejeki IP. ANTIBIOGRAM (Antibiogram). Indonesian Journal Of Clinical Pathology And Medical Laboratory. 2016;23(1):90-5.

Truong WR, Hidayat L, Bolaris MA, Nguyen L, Yamaki J. The antibiogram: key considerations for its development and utilization. JAC-antimicrobial resistance. 2021 Jun 1;3(2):dlab060.

World Health Organization. The WHO AWaRe (access, watch, reserve) antibiotic book. World Health Organization; 2022 Nov 14. Available from: https://iris.who.int/bitstream/handle/10665/365135/WHO-MHP-HPS-EML-2022.02-eng.pdf?sequence=1. Accessed Sep 8, 2024.

Bizri AR, El-Fattah AA, Bazaraa HM, Al Ramahi JW, Matar M, Ali RA, El Masry R, Moussa J, Abbas AJ, Aziz MA. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: a survey-based study and expert opinion. PLoS One. 2023 Jul 27;18(7):e0288550.

Alfetlawi B, Jasim A. Determining the Prevalence of Upper and Lower Urinary Tract Infections’ Pathogens and Their Antibiotic Susceptibility Profile for Adult Patients in Al-Diwaniya, Iraq (Conference Paper). Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2022;31(Suppl.):86-91.

Kurmanji JM, Hassali A, Versporten A, Younus M, Pauwels I, Goossens H, Alnedawi Z. Global point prevalence survey in five teaching hospitals in Baghdad, Iraq. Mediterranean Journal of Infection, Microbes and Antimicrobials/Infectious Diseases and Clinical Microbiology Specialty Society of Turkey. 2021;10:17.

Mustafa BR, Kurdi A. Evaluation of the antimicrobial prescribing pattern and the stewardship programs among COVID-19 hospitals in the capital city of Kurdistan-Northern Iraq: A multicenter point prevalence study. Passer Journal of Basic and Applied Sciences. 2023 Jun 1;5(1):65-71.

Abbas JK, Al-Metwali BZ. The impact of pharmacist behavioral intervention on antibiotics prescribing in pediatric wards. F1000Research. 2023 May 2;12:458.

Ali Azeez Al-Jumaili, Kawther Khalid Ahmed, Eman Sadeq Mawla, Ibrahim Mohammed Majeed, Mohammed D. Al-Rekabi. Irrational Use of Antibiotics in Iraqi Public Hospital. Latin American Journal of Pharmacy, 42 (special issue): 178-183 (2023).

Kurmanji JM, See OG, Al-Jumaili AA, Younus MM. Quality Indicators of Antimicrobials Prescribing in Iraq: A Scoping Review. Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219). 2024 Sep 7;7(1):221-6.

Al-Nema ZM. Trend of Antibiotics Usage in the Intensive Care Unit in the Medical City in Baghdad. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2016;25(1):50-8.

Salih NT, Kadhim DJ. Adherence to American Society of Health-System Pharmacists Surgical Antibiotic Prophylaxis Guideline in Medical City Teaching Hospitals/Baghdad. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2016:40-5.

Hatachi T, Sofue T, Ito Y, Inata Y, Shimizu Y, Hasegawa M, Kugo Y, Yamauchi S, Iwai S, Takeuchi M. Antibiotic prophylaxis for open chest management after pediatric cardiac surgery. Pediatric Critical Care Medicine. 2019 Sep 1;20(9):801-8.

Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. International journal of antimicrobial agents. 2020 Jan 1;55(1):105833.

Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with gram-negative bacteria. Clinical microbiology reviews. 2012 Jul;25(3):450-70.

Feuerstadt P, Nelson WW, Drozd EM, Dreyfus J, Dahdal DN, Wong AC, Mohammadi I, Teigland C, Amin A. Mortality, health care use, and costs of Clostridioides difficile infections in older adults. Journal of the American Medical Directors Association. 2022 Oct 1;23(10):1721-8.

Katchanov J, Asar L, Klupp EM, Both A, Rothe C, König C, Rohde H, Kluge S, Maurer FP. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations. PLoS One. 2018 Apr 12;13(4):e0195757.

Hassan AF, Muhsin SN. Evaluate the Protective Effect of Lactobacillus against Collateral Damage Induced by Ciprofloxacin and Levofloxacin in Iraqi Patients. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2019 Dec 23;28(2):174-9.

Noori YA, Arif IS, Younus MM, Mohammed MM. Analysis of Azithromycin adverse events in COVID-19 Patients reported to Iraqi Pharmacovigilance center in 2020. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2022 Oct 24;22(3):35-42.

Alhamdani FY. Acquired Error in using Antibiotic for Surgery Patients in Iraqi Hospitals. Iraqi Journal of Pharmaceutical Sciences. 2011;20(2):102-6.

Al-Jumaili AA, Younus MM, Kannan YJ, Nooruldeen ZE, Al-Nuseirat A. Pharmaceutical regulations in Iraq: from medicine approval to post-marketing. Eastern Mediterranean Health Journal. 2021 Oct 1;27(10).

Downloads

Published

2025-06-25